Qi Zhou
Chongqing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
Overall survival and long-term safety of olaparib maintenance in patients with platinum-sensitive relapsed ovarian cancer: final analyses of phase III L-MOCA trial.
Journal: Journal of ovarian research
Published: February 10, 2026
A phase I dose-escalation study of Lobaplatin combined with paclitaxel in platinum-sensitive recurrent ovarian epithelial carcinoma: preliminary safety and tolerability supporting clinical trial dosing.
Journal: Gynecologic oncology reports
Published: January 10, 2026
Fuzuloparib with or without apatinib as maintenance therapy in newly diagnosed, advanced ovarian cancer (FZOCUS-1): A multicenter, randomized, double-blind, placebo-controlled phase 3 trial.
Journal: CA: a cancer journal for clinicians
Published: September 15, 2025
Fruquintinib plus sintilimab in patients with advanced endometrial cancer with mismatch-repair proficient status: a multicenter, single-arm, phase Ib/II trial.
Journal: Nature communications
Published: May 19, 2025
Suvemcitug plus chemotherapy in women with platinum-resistant recurrent ovarian cancer: the SCORES randomized, double-blinded, phase 3 trial.
Journal: Nature cancer
Published: April 09, 2025
Corrigendum to 'Efficacy and safety of paclitaxel liposome versus paclitaxel in combination with carboplatin in the first-line chemotherapy for ovarian cancer: a multicenter, open-label, non-inferiority, randomized controlled trial' [Journal of the National Cancer Center 4 (2024) 135-141].
Journal: Journal of the National Cancer Center
Published: March 05, 2025
Safety, Tolerability, and Pharmacokinetics of Mirvetuximab Soravtansine in Chinese Patients With Folate Receptor α-Positive Advanced Ovarian Cancer.
Journal: Cancer medicine
Published: February 17, 2025
Multicenter study of ovarian cancer score for diagnosing ovarian cancer.
Journal: Gynecologic oncology
Published: October 20, 2024
The impact of preoperative immunonutritional status on postoperative complications in ovarian cancer.
Journal: Journal of ovarian research
Published: September 14, 2024
The impact of preoperative immunonutritional status on prognosis in ovarian cancer: a multicenter real-world study.
Journal: Journal of ovarian research
Published: September 11, 2024
Efficacy and safety of paclitaxel liposome versus paclitaxel in combination with carboplatin in the first-line chemotherapy for ovarian cancer: a multicenter, open-label, non-inferiority, randomized controlled trial.
Journal: Journal of the National Cancer Center
Published: December 07, 2023
Last Updated: 09/26/2026